Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Change in Account Payables (2016 - 2026)

Standard Biotools has reported Change in Account Payables over the past 16 years, most recently at $653000.0 for Q4 2025.

  • Quarterly Change in Account Payables rose 842.05% to $653000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.4 million through Dec 2025, up 118.78% year-over-year, with the annual reading at $2.4 million for FY2025, 118.78% up from the prior year.
  • Change in Account Payables was $653000.0 for Q4 2025 at Standard Biotools, down from $946000.0 in the prior quarter.
  • Over five years, Change in Account Payables peaked at $3.4 million in Q1 2021 and troughed at -$10.3 million in Q1 2024.
  • The 5-year median for Change in Account Payables is $211000.0 (2022), against an average of -$264105.3.
  • Year-over-year, Change in Account Payables soared 15758.33% in 2021 and then crashed 772.13% in 2024.
  • A 5-year view of Change in Account Payables shows it stood at $1.4 million in 2021, then plummeted by 190.3% to -$1.3 million in 2022, then skyrocketed by 264.86% to $2.1 million in 2023, then tumbled by 104.19% to -$88000.0 in 2024, then skyrocketed by 842.05% to $653000.0 in 2025.
  • Per Business Quant, the three most recent readings for LAB's Change in Account Payables are $653000.0 (Q4 2025), $946000.0 (Q3 2025), and $1.4 million (Q2 2025).